With the U.S. FDA’s accelerated green light for its DNA therapy targeting recurrent respiratory papillomatosis (RRP), backers of Inovio Pharmaceuticals Inc. began mulling the confirmatory trial and ...
BioWorld tracked 197 clinical trial updates in September 2026, more than double the 93 reported in August. Phase II accounted for the most readouts at 80, followed by phase III with 73 and phase I ...
Potassium-competitive acid blockers (P-CABs) reduce gastric acid secretion by inhibiting H+/K+ ATPase and have been proposed ...
Heartflow Inc. reported data from the Navigate-PCI Registry which showed that the majority of physicians changed their treatment plan ahead of percutaneous coronary intervention (PCI) procedures after ...
Hefei Amvite Pharmaceutical Co. Ltd. and Hefei Industrial Pharmaceutical Institute Co. Ltd. have synthesized new growth hormone secretagogue (GHS) receptor agonists reported to be useful for the ...
H5N1 clade 2.3.4.4b emerged in 2020, causing significant outbreaks in poultry and cattle, and leading to multiple zoonotic infections in humans. Although the current risk of human-to-human ...
Oric Pharmaceuticals Inc. has disclosed new protein/nucleic acid degraders comprising a cereblon-binding moiety coupled to an androgen receptor-targeting moiety through a linker potentially useful for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results